Loading insider details...
Beta
Latest Form 4 (Jun 12, 2026): Grant/Award of 5,000 XLO shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 12, 2026 | Xilio Therapeutics, Inc. (XLO) | Grant/Award | 5,000 | n/a |
| May 23, 2026 | MANNKIND CORP (MNKD) | Grant/Award | 82,781 | n/a |
| Mar 30, 2026 | Xilio Therapeutics, Inc. (XLO) | Purchase | 5,000 | $43.9K |
| Mar 4, 2026 | MANNKIND CORP (MNKD) | Grant/Award | 12,000 | $39.2K |
| Jun 18, 2025 | Xilio Therapeutics, Inc. (XLO) | Purchase | 45,000 | $30.9K |
| Jun 12, 2025 | Xilio Therapeutics, Inc. (XLO) | Grant/Award | 31,000 | n/a |
| May 16, 2025 | MANNKIND CORP (MNKD) | Grant/Award | 52,854 | n/a |
| Jun 17, 2024 | Xilio Therapeutics, Inc. (XLO) | Grant/Award | 50,000 | n/a |
| May 18, 2024 | MANNKIND CORP (MNKD) | Grant/Award | 35,047 | n/a |
| May 27, 2023 | MANNKIND CORP (MNKD) | Grant/Award | 47,393 | n/a |